Goodney Philip P, Likosky Donald S, Cronenwett Jack L
Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03765, USA.
J Vasc Surg. 2009 Jun;49(6):1431-9.e1. doi: 10.1016/j.jvs.2009.02.014.
Surgeons must weigh the morbidity of lower extremity bypass (LEB) with the likelihood of a functional outcome postoperatively. We developed a model to predict ambulation status 1 year after LEB.
We analyzed a prospective registry of 1561 LEB procedures performed for occlusive disease (2003-2005) in 1400 patients (50 surgeons, 11 hospitals). Ambulation status was assessed preoperatively, at discharge, and at 1-year by life-table analysis. Cox proportional hazards models were used to determine predictors of ambulation status 1 year postoperatively.
The indication for surgery was claudication in 25% and critical limb ischemia (CLI) in 75%. Claudicant patients had higher primary (79% vs 73%, P < .001) and secondary (87% vs 81%, P < .001) graft patency rates and were more likely to be alive and ambulatory 1 year postoperatively (96% vs 81%, P < .001) than CLI patients. Amputation rates were 12% for CLI patients and 1% for claudicant patients (P < .001). All claudicant patients walked before surgery, and the 95% who survived 1 year postoperatively remained ambulatory. Preoperatively, 93% of CLI patients were ambulatory, and 88% of the survivors at 1 year remained ambulatory. The risk of dying or being nonambulatory 1 year postoperatively was increased in patients who were nonambulatory preoperatively (hazard ratio [HR], 1.5; 95% confidence interval [CI], 1.3-1.6; P < .0001), by increasing age of 70-79 (HR, 1.8; 95% CI, 1.2-2.6; P < .007) and 80-89 years (HR, 2.3; 95% CI, 1.5-3.7; P < .0001), by CLI (HR, 2.0; 95% CI, 1.2-3.4; P < .007), by postoperative myocardial infarction (HR, 2.5; 95% CI, 1.6-4.1; P < .001), and by major amputation (HR, 2.9; 95% CI, 2.1-4.1; P < .001). Graft thrombosis during follow-up (HR, 1.6; 95% CI, 1.1-1.8; P < .003) and living in a nursing home preoperatively (HR, 3.5; 95% CI, 1.5-7.8; P < .003) were independently associated with a higher risk of being nonambulatory at 1 year.
Ambulatory and independent living status are well preserved after LEB. Risk factors of age, preoperative ambulatory ability, independent living status, CLI, graft patency, and amputation help to predict ambulatory status 1 year postoperatively. The likelihood of death or nonambulatory status at 1 year was <5% in patients with none of these risk factors to nearly 50% in patients with three or more risk factors. These variables can be used to inform decision making about whether patients should undergo LEB.
外科医生必须权衡下肢搭桥术(LEB)的发病率与术后功能恢复的可能性。我们开发了一个模型来预测LEB术后1年的行走状态。
我们分析了2003年至2005年在11家医院由50名外科医生为1400例患者实施的1561例针对闭塞性疾病的LEB手术的前瞻性登记数据。通过生命表分析在术前、出院时和1年时评估行走状态。使用Cox比例风险模型来确定术后1年行走状态的预测因素。
手术指征为间歇性跛行的患者占25%,严重肢体缺血(CLI)的患者占75%。与CLI患者相比,间歇性跛行患者的移植血管原发性通畅率(79%对73%,P <.001)和继发性通畅率(87%对81%,P <.001)更高,术后1年存活且能行走的可能性也更大(96%对81%,P <.001)。CLI患者的截肢率为12%,间歇性跛行患者为1%(P <.001)。所有间歇性跛行患者术前都能行走,术后存活1年的患者中有95%仍能行走。术前,93%的CLI患者能行走,1年后存活的患者中有88%仍能行走。术前不能行走的患者术后1年死亡或不能行走的风险增加(风险比[HR],1.5;95%置信区间[CI],1.3 - 1.6;P <.0001),年龄增加到70 - 79岁(HR,1.8;95% CI,1.2 - 2.6;P <.007)和80 - 89岁(HR,2.3;95% CI,1.5 - 3.7;P <.0001),CLI(HR,2.0;95% CI,1.2 - 3.4;P <.007),术后心肌梗死(HR,2.5;95% CI,1.6 - 4.1;P <.001),以及大截肢(HR,2.9;95% CI,2.1 - 4.1;P <.001)。随访期间移植血管血栓形成(HR,1.6;95% CI,1.1 - 1.8;P <.003)和术前住在养老院(HR, 3.5;95% CI,1.5 - 7.8;P <.003)与术后1年不能行走的风险独立相关。
LEB术后行走和独立生活状态得到良好维持。年龄、术前行走能力、独立生活状态、CLI、移植血管通畅情况和截肢等风险因素有助于预测术后1年的行走状态。没有这些风险因素的患者术后1年死亡或不能行走的可能性小于5%,而有三个或更多风险因素的患者这一可能性接近50%。这些变量可用于指导关于患者是否应接受LEB的决策。